ZBIO
ZBIO clinical trials: Zenas BioPharma, Inc.
Every trial on ClinicalTrials.gov where Zenas BioPharma, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 10
- Trials linked
- 10
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
ZBIO on the catalyst calendar · ZBIO registry changes
- Primary completion Sep 23, 2026ActualPhase 2NCT06559163A Study of Obexelimab in Patients With Systemic Lupus ErythematosusZenas BioPharma (USA), LLC · Systemic Lupus ErythematosusActive, not recruitingZBIOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2030Sponsor estimatePhase 3NCT07299019A Study of Orelabrutinib in Patients With Secondary Progressive Multiple SclerosisZenas BioPharma (USA), LLC · Secondary Progressive Multiple SclerosisRecruitingZBIOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2030Sponsor estimatePhase 3NCT07067463A Study of Orelabrutinib in Patients With Primary Progressive Multiple SclerosisZenas BioPharma (USA), LLC · Multiple Sclerosis (MS) Primary ProgressiveRecruitingZBIOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 16, 2026ActualPhase 1NCT05638854A Study to Evaluate Safety and Pharmacokinetics of ZB002 in Healthy Participants and Participants With Rheumatoid ArthritisZenas BioPharma (USA), LLC · Healthy VolunteersCompletedZBIOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 13, 2025ActualPhase 3NCT05662241A Phase 3 Study of Obexelimab in Patients With IgG4-Related DiseaseZenas BioPharma (USA), LLC · IgG4 Related DiseaseActive, not recruitingZBIOLeadBMYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 28, 2025ActualPhase 2NCT06564311A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)Zenas BioPharma (USA), LLC · Relapsing Multiple SclerosisActive, not recruitingZBIOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 30, 2026Sponsor estimatePhase 3NCT05786573A Study of Obexelimab in Patients With Warm Autoimmune Hemolytic Anemia (SApHiAre)Zenas BioPharma (USA), LLC · Warm Autoimmune Hemolytic AnemiaActive, not recruitingZBIOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 17, 2024ActualPhase 1NCT05776121Study of ZB001 in Chinese Patients With Thyroid Eye DiseaseZenas BioPharma (USA), LLC · Thyroid Eye DiseaseCompletedZBIOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 21, 2024ActualPhase 1NCT05794516A Safety and Pharmacokinetics Study of ZB004 in Healthy ParticipantsZenas BioPharma (USA), LLC · Healthy VolunteersCompletedZBIOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 4, 2023ActualPhase 1NCT05542303A Safety, Tolerability and Pharmacokinetics Study of ZB001 in Healthy SubjectsZenas BioPharma (USA), LLC · Healthy VolunteersCompletedZBIOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 10 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner